Business Context and Reporting Period
This Form 8-K is a current report filed by Reviv3 Procare Company (not Axil Brands, Inc.) on August 22, 2023. The filing serves to announce the Company's consolidated financial results for the fourth quarter ended May 31, 2023. The detailed results are contained in a press release furnished as Exhibit 99.1, which is incorporated by reference but not deemed "filed" under Section 18 of the Exchange Act.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), the content of which is not included in the provided source text.
Material Changes
No specific material changes versus the prior comparable period are quantified in the body of this Form 8-K. The document solely acts as a notification that the Q4 2023 results have been issued.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies within the main text. Such information, if present, would be located in the referenced Exhibit 99.1 press release.
Investor Verification Checklist
- Verify the correct registrant name is Reviv3 Procare Company, as the input metadata incorrectly listed "Axil Brands, Inc."
- Access Exhibit 99.1 (the Earnings Press Release) to obtain actual financial figures for the quarter ended May 31, 2023.
- Confirm the Company's status as an emerging growth company (the form indicates this box was checked).
- Note that the financial data in the press release is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.